New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 16, 2013
09:22 EDTMNKDSummer Street says 'suspicious' of MannKind AFFINITY trial
Summer Street says it has become "suspicious" of the results from MannKind's AFFINITY trial since the company released data on only two of three arms of the study. The firm says MannKind released the results on the injectable insulin and Dreamboat arms but withheld the results on the Medtone C-arm, which the firm says is "unprecedented." Summer Street does not have an official rating on shares of MannKind.
News For MNKD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 12, 2014
08:01 EDTMNKDPiper predicts two large-cap biotechs could be acquired in 2015
Subscribe for More Information
December 8, 2014
05:50 EDTMNKDStocks with implied volatility movement; AVNR MNKD
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use